Cargando…
Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study
BACKGROUND: Primary retroperitoneal lymph node dissection (RPLND) ultimately lost its role as the standard management of clinical stage (CS) 1 nonseminomatous (NS) testicular germ cell tumours (GCTs) in Europe when the European Germ Cell Cancer Consensus Group released their recommendations in 2008....
Autores principales: | Dieckmann, K.-P., Anheuser, P., Kulejewski, M., Gehrckens, R., Feyerabend, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204050/ https://www.ncbi.nlm.nih.gov/pubmed/30367648 http://dx.doi.org/10.1186/s12894-018-0412-x |
Ejemplares similares
-
Retroperitoneal lymph node dissection for residual masses after chemotherapy
in nonseminomatous germ cell testicular tumor
por: Luz, Murilo A, et al.
Publicado: (2010) -
Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences
por: Nowroozi, Mohamadreza, et al.
Publicado: (2015) -
Anatomical retroperitoneoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors: Initial operative experience
por: Yao, Kai, et al.
Publicado: (2014) -
Extraperitoneal robot-assisted laparoscopic retroperitoneal lymph node dissection for early-stage testicular nonseminomatous germ cell tumors: A case report and literature review
por: Qin, Jie, et al.
Publicado: (2017) -
A retrospective analysis of patients undergoing postchemotherapy retroperitoneal lymph node dissection and metastasectomy in advanced nonseminomatous germ cell tumors
por: Malik, Kanuj, et al.
Publicado: (2020)